Evidence map›Paper›PMID 20876216›Full record

ArticleFASEB journal : official publication of the Federation of American Societies for Experimental Biology2011

PECAM-targeted delivery of SOD inhibits endothelial inflammatory response.

Vladimir V Shuvaev, Jingyan Han, Kevin J Yu, Shaohui Huang, Brian J Hawkins, Muniswamy Madesh, Marian Nakada, Vladimir R Muzykantov

Abstract read
In one paragraph

Article in FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 55 papers.

0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed
3.4field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

55 citing papers in PubMed, 91 citations in OpenAlex.

  1. Article
  2. Equip your vehicle for the right terrain: Using features of local pathology to guide engineering of targeted drug delivery systems.Journal of controlled release : official journal of the Controlled Release Society · 2026
    Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Bivalent engagement of endothelial surface antigens is critical to prolonged surface targeting and protein delivery in vivo.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2020
    Article
  10. Review
  11. Article
  12. Reactive oxygen species modulate NaAmerican journal of physiology. Heart and circulatory physiology · 2019
    Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Targeting therapeutics to endothelium: are we there yet?Drug delivery and translational research · 2018
    Review
  18. Ferritin-based drug delivery systems: Hybrid nanocarriers for vascular immunotargeting.Journal of controlled release : official journal of the Controlled Release Society · 2018
    Review
  19. Review
  20. Targeting superoxide dismutase to endothelial caveolae profoundly alleviates inflammation caused by endotoxin.Journal of controlled release : official journal of the Controlled Release Society · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Vladimir V ShuvaevInstitute for Environmental Medicine, Department of Pharmacology, University of Pennsylvania School of Medicine, 1 John Morgan Bldg., 3620 Hamilton Walk, Philadelphia, PA 19104-6068, USA.
Jingyan Han
Kevin J Yu
Shaohui Huang
Brian J Hawkins
Muniswamy Madesh
Marian Nakada
Vladimir R Muzykantov
University of Pennsylvania · USReaction Biology Corporation (United States) · USTemple University · US

Funding

Reactive oxygen species and anti-oxidants in ALIP01HL079063 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI FEINSTEIN, SHELDON I · 2005 to 2009
$12.1M
Coordination of Pathophysiologic Endothelial Cell Signaling by ROSR01HL086699 · NHLBI · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI MUNISWAMY, MADESH · 2008 to 2018
$4.3M
Targeting Carriers with Controlled Geometry to EndotheliumR01HL087036 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI MUZYKANTOV, VLADIMIR R · 2008 to 2012
$2.0M
Augmentation of Antioxidant Defenses by ImmunotargetingR01HL073940 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI MUZYKANTOV, VLADIMIR R · 2004 to 2007
$1.6M
Regulation of vascular inflammation by mitochondrial reactive oxygen speciesR00HL094536 · NHLBI · UNIVERSITY OF WASHINGTON · PI HAWKINS, BRIAN J. · 2010 to 2012
$744k
Multiphoton upgrade of confocal microscope for live organ and tissue imagingS10RR022511 · NCRR · UNIVERSITY OF PENNSYLVANIA · PI MUNISWAMY, MADESH · 2007 to 2007
$500k
Regulation of vascular inflammation by mitochondrial reactive oxygen speciesK99HL094536 · NHLBI · TEMPLE UNIV OF THE COMMONWEALTH · PI HAWKINS, BRIAN J. · 2009 to 2010
$180k
NCRR NIH HHS 1S10RR022511NCRR NIH HHS S10 RR022511NHLBI NIH HHS HL086699NHLBI NIH HHS HL087036NHLBI NIH HHS K99 HL094536NHLBI NIH HHS K99HL094536NHLBI NIH HHS P01 HL079063NHLBI NIH HHS R00 HL094536NHLBI NIH HHS R01 HL073940NHLBI NIH HHS R01 HL086699NHLBI NIH HHS R01 HL087036
6 · The paper itself

Abstract

Elevated generation of reactive oxygen species (ROS) by endothelial enzymes, including NADPH-oxidase, is implicated in vascular oxidative stress and endothelial proinflammatory activation involving exposure of vascular cell adhesion molecule-1 (VCAM-1). Catalase and superoxide dismutase (SOD) conjugated with antibodies to platelet/endothelial cell adhesion molecule 1 (PECAM-1) bind specifically to endothelium and inhibit effects of corresponding ROS, H(2)O(2), and superoxide anion. In this study, anti-PECAM/SOD, but not anti-PECAM/catalase or nontargeted enzymes, including polyethylene glycol (PEG)-SOD, inhibited 2- to 3-fold VCAM expression caused by tumor necrosis factor (TNF), interleukin-1β, and lipopolysaccharide. Anti- PECAM/SOD, but not nontargeted counterparts, accumulated in vascular endothelium after intravenous injection, localized in endothelial endosomes, and inhibited by 70% lipopolysaccharide-caused VCAM-1 expression in mice. Anti-PECAM/SOD colocalized with EEA-1-positive endothelial vesicles and quenched ROS produced in response to TNF. Inhibitors of NADPH oxidase and anion channel ClC3 blocked TNF-induced VCAM expression, affirming that superoxide produced and transported by these proteins, respectively, mediates inflammatory signaling. Anti-PECAM/SOD abolished VCAM expression caused by poly(I:C)-induced activation of toll-like receptor 3 localized in intracellular vesicles. These results directly implicate endosomal influx of superoxide in endothelial inflammatory response and suggest that site-specific interception of this signal attained by targeted delivery of anti-PECAM/SOD into endothelial endosomes may have anti-inflammatory effects.

Indexed as

Antibodies, MonoclonalBlotting, WesternCell LineChloride ChannelsDrug Delivery SystemsEndocytosisEndosomesEndothelial CellsEndothelium, VascularHumansImmunoconjugatesInjections, IntravenousInterleukin-1betaLipopolysaccharidesLungMicroscopy, FluorescenceAntibodies, MonoclonalChloride ChannelsClC-3 channelImmunoconjugatesInterleukin-1betaLipopolysaccharidesNADPH OxidasesPlatelet Endothelial Cell Adhesion Molecule-1Superoxide DismutaseSuperoxidesTumor Necrosis Factor-alphaVascular Cell Adhesion Molecule-1

Identifiers

PMID20876216
PMCPMC3005426
OpenAlexW2038486742

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.